HA
Haw Par Corporation Limited
HAWPF · OTC
$10.80 +0.00% (+$0.00)
Market Cap $3.06B
P/E Ratio 11.54x
Div. Yield 2.92%
ROE 6.15%
Bulios Fair Price
$14.59
35.1% upside
Current Price
$10.8
Undervalued Fair Value Overvalued
According to Bulios Fair Price, HAWPF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
6/9Valuation
65 /100
Fair EV/EBITDA 31.52x
P/S 13.32x
P/B 0.71x
Growth
81 /100
Growing Rev. growth 8.06%
FCF growth 133.20%
Book val. growth 6.51%
Profitability
100 /100
Strong Net margin 115.44%
Op. margin 29.17%
FCF margin 117.05%
Quality
18 /100
Poor ROE 6.15%
ROA 6.01%
Asset turnover 0.05x
Debt
100 /100
Low Current ratio 7.13x
Int. coverage 44.05x
Net debt/EBITDA -10.17x
Stability
60 /100
Moderate Rev. volatility 17.05%
EPS volatility 21.25%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about HAWPF
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Ee Lim Wee
Employees
595
Headquarters
Singapore